Separating graft-versus-tumor from graft-versus-host reactions

Leukemia and Lymphoma

Volumn 43, Issue 4, 2002, Pages 725-733

  Fassas, A B T ^a   Morris, C ^a   Badros, A ^b   Van Rhee, F ^a   Tricot, G ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

Allogeneic stem cell transplant; Graft versus host disease; Graft versus tumor effect; Lymphocyte

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; ETOPOSIDE; GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; RITUXIMAB; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; CANCER RECURRENCE; CHILD; CONTROLLED STUDY; CYTOTOXICITY; DISEASE SEVERITY; EFFECTOR CELL; FEMALE; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HEMATOLOGIC DISEASE; HUMAN; IMMUNE DEFICIENCY; IMMUNOSTIMULATION; INCIDENCE; LEUKEMIA; MALE; MOLECULAR BIOLOGY; PRIORITY JOURNAL; PUBLICATION; RECURRENCE RISK; REVIEW; STEM CELL TRANSPLANTATION; T LYMPHOCYTE;

ANIMALS; GRAFT VS HOST DISEASE; GRAFT VS HOST REACTION; GRAFT VS TUMOR EFFECT; HUMANS; IMMUNE TOLERANCE; LEUKEMIA; LYMPHOCYTE DEPLETION; STEM CELL TRANSPLANTATION;

EID: 0036238877     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190290016818     Document Type: Review

References (72)

1. "Graft-vs-leukemia effect in clinical bone marrow transplantation"
2. "Graft versus leukemia"
3. "The graft-versus-leukemia effect"
4. "The Seattle marrow transplant team: Antileukemic effect of chronic graft-versus-host disease. Contribution to improved survival after allogeneic marrow transplantation"
5. "How does bone-marrow transplantation cure leukaemia?"
6. "Graft-versus-leukemia reactions after bone marrow transplantation"
7. "Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation"
8. "Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients"
9. "Toxicity and efficacy of defined doses of CD4+ donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant"
10. "Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: Efficacy and toxicity of a defined T-cell dose"
11. "Graft-versus-host disease"
12. "Cytokine cascades in acute graft-versus-host disease"
13. "Fas and perforin pathways as major mechanisms of T cell-medicated cytotoxicity"
14. "Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways"
15. "T-cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation"
16. "Selective depletion of bone marrow T lymphocytes with anti-CD5 monoclonal antibodies: Effective prophylaxis for graft-versus-host disease in patients with hematologic malignancies"
17. "T-cell depletion of HLA-identical transplants in leukemia"
18. "Epstein-Barr virus associated B-cell lymphoproliferative disorders following bone marrow transplantation"
19. "Epstein-Barr virus lymphoproliferation after bone marrow transplantation"
20. "Contribution of CD4+ and CD8+ T cells to graft-versus-host disease and graft-versus-leukemia reactivity after transplantation of MHC-compatible bone marrow"
21. "The graft-versus-leukemia (GVL) phenomenon: Is GVL separable from GVHD?"
22. "Biology of graft-vs-host disease"
23. "Prediction of graft-versus-host disease by phenotypic analysis of early immune reconstitution after DC6-depleted allogeneic bone marrow transplantation"
24. "Selective depletion of CD8+ cells for prevention of graft-versus-host disease after bone marrow transplantation. A randomized controlled trial"
25. "CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation"
26. "CD8-deplete donor lymphocyte infusion (DLI) for the treatment of CCML relapse after allogeneic transplant: Long term follow up and factors predicting outcome"
27. "CD6-depleted allogeneic bone marrow transplantation for acute leukemia in first complete remission"
28. "CD6+ T cell-depleted allogeneic bone marrow transplantation for non-Hodgkin's lymphoma"
29. "CD6+ donor marrow T-cell depletion as the sole for of graft-versus-host disease prophylaxis in patients undergoing allogeneic bone marrow transplant from unrelated donors"
30. "Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasm"
31. "Relationship between graft-versus-host disease and graft-versus-leukaemia in partial T cell-depleted bone marrow transplantation"
32. "Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation"
33. "Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplantation: Where we now stand"
34. "Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: Separation of graft-versus-host disease"
35. "Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia"
36. "Donor lymphocyte infusions (DLI) in patients with chronic myeloid leukemia following allogeneic bone marrow transplantation"
37. "Transplantation of anergic histoincompatible bone marrow allografts"
38. "Signals arising from antigen-presenting cells"
39. "A theory of self-nonself discrimination"
40. "Thymidine kinase (TK) gene-transduced human lymphocytes can be highly purified, remain fully functional, and are killed efficiently with ganciclovir"
41. "HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia"
42. "Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft"
43. "Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease"
44. "Delayed infusion of immunocompetent donor cells after bone marrow transplantation breaks graft-host tolerance and allows for persistent antileukemic reactivity without severe graft-versus-host disease"
45. "T cell-depleted allogeneic bone marrow transplantation for acute leukaemia using Campath-1 antibodies and post-transplant administration donor's peripheral blood lymphocytes for prevention of relapse"
46. "T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect"
47. "Allogeneic bone marrow transplantation for CML: A report from the International Bone Marrow Transplant Registry"
48. "Marrow transplantation for CML: The Seattle experience"
49. "Marrow transplantation for patients in accelerated phase of chronic myeloid leukemia"
50. "Allogeneic bone marrow transplantation for chronic myeloid leukaemia"
51. "Allogeneic bone marrow transplantation in multiple myeloma"
52. "Factors influencing outcome in de novo myelodysplastic syndromes treated by allogeneic bone marrow transplantation: A long-term study"
53. "Controlled graft-versus-host reaction in the treatment of leukemia in mice"
54. "Graft versus leukemia in bone marrow transplantation"
55. "Time pattern of the antileukemic effect of graft-versus-host reaction"
56. "Incidence of acute graft-versus-host disease with and without methotrexate prophylaxis in allogeneic bone marrow transplant patients"
57. "Hyperacute graft-v-host disease in patients not given immunosuppression after allogeneic marrow transplantation"
58. "Encouraging preliminary results in 12 patients with high-risk haematological malignancies by omitting graft-versus-host disease prophylaxis after allogeneic transplantation"
59. "Anti-thymocyte-globulin as part of the preparative regimen prevents graft failure and severe graft versus host disease (GVHD) in allogeneic stem cell transplantation from unrelated donors"
60. "Increased risk of leukemia relapse with high-dose cyclosporine A after allogeneic marrow transplantation for acute leukemia"
61. "Graft versus host disease prophylaxis with low-dose cyclosporine-A reduces the risk of relapse with acute leukemia given HLA-identical sibling bone marrow transplantation: Results of a randomized trial"
62. "Low-dose cyclosporine of short duration increases the risk of mild and moderate GVHD and reduces the risk of relapse in HLA-identical sibling marrow transplant recipients with leukaemia"
63. "Specific depletion of alloreactive T cells in HLA-identical siblings: A method for separating graft-versus-host and graft-versus leukaemia reactions"
64. "Prediction of graft versus host disease by frequency analysis of cytotoxic T cells after unrelated donor bone marrow transplantation"
65. "The frequency of pretransplant donor cytotoxic T cell precursors with anti-host specificity predicts survival of patients transplanted with bone marrow from donors other than HLA-identical siblings"
66. "Complete remission of accelerated phase chronic myeloid leukemia by treatment with leukemia-reactive cytotoxic T lymphocytes"
67. "Harnessing graft-versus-malignancy: Non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy"
68. "The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: Rationale for the use of cytokine shields in allogeneic bone marrow transplantation"
69. "Keratinocyte growth factor separates graft-versus-leukemia effects from graft-versus-host disease"
70. "Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation"
71. "LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation"
72. "Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect"